Streamlining Stem Cell Manufacturing
The Factory System Will Help the Stem Cell Industry Standardize, Integrate, and Automate Unit Operations
More Tooth, More Tail in CRISPR Operations
The Most Interesting Thing about CRISPR/Cas9 Is What It Can Accomplish in the Hands of Gifted Researchers
DNA: Past to Present 2017
Celebrate National DNA Day with a Look at Some of the Double-Helix’s Scientific History
Predict Drug Toxicity without Guesswork
Consider Organs-On-Chips, Pathway Simulations, and Transgenic Mice
The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.
New research may eventually lead to orally ingestible bacteria for monitoring gut health and disease—with the ultimate goal being the development of a home inflammation test.
Mary Woolley, President of Research!America, which advocates for medical and health research funding, talks about how her group and other advocates plan to fight back against President Donald Trump’s one-two punch to NIH funding. Researchers will be key to those efforts, she says.
McGill University researchers may have found a natural way to cut down on antibiotic use without sacrificing health.
A recent study suggest that children with sensitive genotypes who come from low-income homes will be less financially successful than their same sex sibling without those genotypes. But children with those same genotypes from a high-income home would actually fare better economically as young adults than their brother or sister.
Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?
Scientists have long written off cannibalism as a strange phenomenon with little biological significance. However, the true nature of cannibalism—the role it plays in evolution as well as human history—is even more intriguing (and more normal) than the misconceptions we’ve come to accept as fact.
Nicole M. Nichols, Ph.D., group leader for DNA amplification development at New England Biolabs, discusses the third national Genes in Space competition. The winner will have his or her experiment carried out aboard the International Space Station.
Bill Warren, partner with the law firm Eversheds Sutherland and chair of its biotechnology and life sciences team, discusses the ruling by a three-judge panel of the Patent Trial and Appeal Board siding with the Broad Institute of MIT and Harvard in the bitter legal battle over who invented CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology.
Finding in female mice may also be relevant to certain human psychiatric disorders.
Jodie Morrison, CEO and President of Tokai Pharmaceuticals, is one of nearly 200 biopharma leaders who recently signed an open letter endorsing a Top Ten of best practices for advancing gender diversity, from the boardroom to the C-suite to the lab.
Findings from a new study suggest that the onset of high blood pressure later in life is associated with lower dementia risk after age 90. Listen now for more details!
Entasis Therapeutics is working on novel therapies for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.
Benjamin Corb, public affairs director for the American Society for Biochemistry and Molecular Biology (ASBMB), discusses what the biomedical research community can expect from the incoming administration of Donald J. Trump.
The next generation of toys could be controlled by the power of the mind, thanks to researchers at the University of Warwick who have recently developed electronic devices to be activated using electrical impulses from brain waves, by connecting our thoughts to computerized systems.
A new survey led by researchers at Stanford University School of Medicine asked a representative group of adults 65 and older, how willing they would be to learn about their possible cognitive decline. Listen now for more details!
Jay Jackson, manager with Avalere Health, discusses the 21st Century Cures Act, which recently passed both houses of Congress by overwhelming majorities. The measure has long been championed by supporters as a vehicle for speeding up approval of new drugs and maintaining U.S. leadership in research. Critics say the bill does too much for big pharma and not enough for patients seeking relief from rising drug prices.
Scientists in Ireland have solved a mystery regarding the cause of especially smelly camel urine. Their research has implications for the millions of people affected by African parasites called trypanosomes, which frequently cause death from sleeping sickness.
David G. Maloney, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, discusses the new Bezos Family Immunotherapy Clinic, a first-of-its-kind facility focused on providing cancer immunotherapies to patients.
Findings from a new retrospective study has found that active marijuana use could increase the risk for developing a rare cardiovascular event.
A new computer analysis from investigators at the MD Anderson Cancer Center suggests that traces of long-lost human cousins may be buried in modern people’s DNA.